Stockscreener 앱 받기
40.95
25.23%
8.25
시간 외 거래:
41.24
0.29
+0.71%
전일 마감가:
$32.70
열려 있는:
$38.49
하루 거래량:
1.71M
Relative Volume:
4.22
시가총액:
$1.75B
수익:
$384.90M
순이익/손실:
$-851.00K
주가수익비율:
-2,047.50
EPS:
-0.02
순현금흐름:
$12.83M
1주 성능:
+32.44%
1개월 성능:
+33.91%
6개월 성능:
+34.04%
1년 성능:
+61.67%
1일 변동 폭
$38.05
$40.96
1주일 범위
$31.04
$40.96
52주 변동 폭
$21.97
$40.96
Artivion Inc Stock (AORT) Company Profile
명칭
Artivion Inc
전화
(770) 419-3355
주소
1655 ROBERTS BOULEVARD N W, KENNESAW
AORT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
40.95 | 1.52B | 384.90M | -851.00K | 12.83M | -0.02 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-17 | 개시 | Canaccord Genuity | Buy |
| 2024-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-27 | 재확인 | Lake Street | Buy |
| 2022-08-08 | 개시 | Lake Street | Buy |
| 2022-03-03 | 개시 | Stifel | Buy |
Artivion Inc 주식(AORT)의 최신 뉴스
Artivion Surges on Improved 2025 Financial Outlook - StocksToTrade
Artivion’s Stocks Surge as Q2 Financials Exceed Expectations - timothysykes.com
Canaccord Genuity Group Forecasts Strong Price Appreciation for Artivion (NYSE:AORT) Stock - Defense World
What technical models suggest about Artivion Inc.’s comebackPredictive Short-Term Market Reversal Alerts - Newser
Artivion raises 2025 revenue guidance to $435M–$443M as On-X and stent grafts drive double-digit growth - MSN
Artivion's Q2 Earnings Surge: A High-Margin Medical Innovation Play with Undervalued Potential - AInvest
Artivion, Inc.'s (NYSE:AORT) 26% Jump Shows Its Popularity With Investors - 富途牛牛
Artivion price target raised to $45 from $32 at Needham - Yahoo Finance
Artivion Second Quarter 2025 Earnings: Beats Expectations - uk.finance.yahoo.com
Needham & Company LLC Reaffirms Buy Rating for Artivion (NYSE:AORT) - MarketBeat
Artivion Elevates 2025 Revenue Projection Amid Strong Q2 Earnings - StocksToTrade
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $40 to $45 - 富途牛牛
Artivion 2025 Q2 Earnings Strong Performance with Net Income Surges 163% - AInvest
Artivion price target raised to $41 from $35 at Canaccord - MSN
Zurcher Kantonalbank Zurich Cantonalbank Raises Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion (NYSE:AORT) Shares Gap Up on Better-Than-Expected Earnings - Defense World
Is Artivion Inc. stock heavily shortedBest ROI Stock Strategies - thegnnews.com
Can Artivion Inc. ride the EV waveFree Pre-Market Movers Report - mustnews.co.kr
Artivion (NYSE:AORT) Stock Rating Upgraded by Wall Street Zen - Defense World
Comparing Artivion Inc. in custom built stock radarsSector-Wise Equity Performance Trend Forecast - Newser
Artivion Inc. stock trend forecastFree Swing Trading Entry Point Signals - Newser
Artivion’s Surging Stock: Rising Star or Temporary Miracle? - timothysykes.com
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $35 to $45 - 富途牛牛
Artivion (AORT): Accelerating Growth and Margin Expansion in a High-Margin Medical Device Niche - AInvest
Artivion Raises 2025 Revenue Guidance to $435M-$443M, Driven by On-X and Stent Grafts. - AInvest
Why Is Artivion (AORT) Stock Rocketing Higher Today - Yahoo Finance
Artivion: JMP Securities Raises PT to $42 from $33, Maintains Market Outperform - AInvest
ARTIVION, INC. SEC 10-Q Report - TradingView
Artivion stock price target raised by Stifel to $40 on strong AMDS launch - Investing.com Nigeria
Needham raises Artivion stock price target to $45 on growth acceleration - Investing.com Australia
High Insider Ownership and Revenue Growth: Top US Growth Companies - AInvest
Artivion stock price target raised to $41 from $35 at Canaccord on strong Q2 - Investing.com UK
Artivion price target raised to $42 from $33 at Citizens JMP - TipRanks
Oppenheimer raises Artivion stock price target to $40 on strong Q2 results - Investing.com
Artivion revenue up 15% to USD 113M in Q2 2025 - Medical Buyer
Oppenheimer lowers Artivion stock price target to $40 from $42, maintains Outperform By Investing.com - Investing.com South Africa
Artivion's (NYSE:AORT) growing losses don't faze investors as the stock lifts 5.8% this past week - simplywall.st
Earnings call transcript: Artivion Q2 2025 reports strong revenue growth By Investing.com - Investing.com Canada
Earnings call transcript: Artivion Q2 2025 reports strong revenue growth - Investing.com
Artivion Q2 2025 slides: Revenue jumps 14%, guidance raised on strong product growth - Investing.com Nigeria
Artivion stock price target raised to $42 from $33 at JMP on strong growth - Investing.com Nigeria
Artivion (NYSE:AORT) Reports Strong Q2, Stock Jumps 13.1% - TradingView
Artivion’s Revenue And Profits Beat Expectations With Debt Cutback - Finimize
Artivion: Q2 Earnings Snapshot - Connecticut Post
Artivion Inc (AORT) Q2 2025 Earnings Call Highlights: Strong Rev - GuruFocus
Transcript : Artivion, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Is now a turning point for Artivion Inc.Free Swing Trading Entry Point Signals - Newser
Artivion Inc. Reports Strong Q2 2025 Earnings - TipRanks
Will Artivion Inc. stock benefit from interest rate changesPortfolio Review Summary with Five-Year Outlook - Newser
Artivion Inc reports results for the quarter ended June 30Earnings Summary - TradingView
How to interpret RSI for Artivion Inc. stockWeekly Trend Screener with Momentum Picks - Newser
Artivion Inc (AORT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):